As Artificial Intelligence continues to dominate headlines and industries, the Cornell University College of Veterinary Medicine (CVM) remains a ...
In an effort to guarantee "the ongoing quality, safety, nutritional adequacy, and resilience of the domestic infant formula ...
Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...
CMND-100, a proprietary MEAI-based oral drug candidate, represents a potential breakthrough in AUD treatment, targeting the reduction of alcohol consumption and cravings through a novel mechanism of ...
A new tool about chemical contaminants in human and animal foods is available from the FDA. The Chemical Contaminants Transparency Tool is the latest ...
Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
Highlights Calculation of patent term extension for drug products under regulatory review is based on the issue date of the original patent, not the reissue patent (if there is one), a recent court ...
If you wish to instantly get the details of any other registration, enter the vehicle number in the search box below.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback